Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Pain. 2012 Apr 13;153(6):1232–1243. doi: 10.1016/j.pain.2012.02.035

Figure 4. Sensitivity to noxious heat stimuli and offset analgesia at time points after termination of remifentanil infusion and after administration of naloxone (N=19).

Figure 4

Subjects displayed increased sensitivity over time to constant 49°C, 40 s stimuli (A, Peak VAS) and to 49-50-49°C stimuli (B, MaxT2). However, minimum values during offset analgesia were not significantly altered following naloxone or remifentanil administration (C, Min Offset). Likewise, Magnitude Offset Analgesia (MaxT2 – Min Offset) was also not significantly altered (D). Time to the minimum ratings of offset analgesia was shorter following remifentanil compared to naloxone (E, Min Offset Latency), however, no after sensations were observed (F, VAS End Latency). Mean ± SEM; VAS, visual analogue scale.